Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sophia von Martial1, Athanasios Tsianakas2

  • 1Klinik für Dermatologie und Allergologie, Fachklinik Bad Bentheim, Am Bade 1, 48455, Bad Bentheim, Deutschland.

Dermatologie (Heidelberg, Germany)
|February 20, 2024
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Nemolizumab at Week 48: Results from the Maintenance Phase of Two Global Phase 3 Pivotal Studies (ARCADIA 1&2) in Patients with Moderate-to-Severe Atopic Dermatitis.

Acta dermato-venereologica·2026
Same author

Tildrakizumab Real-World Experience (T-REX) in Plaque Psoriasis: Meta-Analysis of Four Non-interventional Studies.

Dermatology and therapy·2026
Same author

Impact of Oral DFD-29, a Low-Dose Formulation of Minocycline, on Quality of Life in Patients with Rosacea: Results of Two Phase 3 Randomized Controlled Trials.

The Journal of clinical and aesthetic dermatology·2025
Same author

Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial.

Journal of the American Academy of Dermatology·2025
Same author

Efficacy and safety of lebrikizumab in adult and adolescent patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin A: a placebo-controlled, randomized phase IIIb clinical study (ADvantage).

The British journal of dermatology·2025
Same journal

Dermatologie (Heidelberg, Germany)·2026
Same journal

[Medical care situation of people with vitiligo : A pilot and feasibility study on guideline-oriented management in German dermatology practices].

Dermatologie (Heidelberg, Germany)·2026
Same journal

[Erythroderma: etiology, diagnosis, and management-an overview].

Dermatologie (Heidelberg, Germany)·2026
Same journal

[New drug therapy approaches in the management of hidradenitis suppurativa].

Dermatologie (Heidelberg, Germany)·2026
Same journal

[Chronic hyperkeratotic plaques on the fingers and axillae in a mother and daughter].

Dermatologie (Heidelberg, Germany)·2026
Same journal

[63/m with a painful mass on the forehead following kidney transplantation : Preparation for the medical specialist examination: part 61].

Dermatologie (Heidelberg, Germany)·2026
See all related articles